PhysIQ Received FDA Clearance for Algorithm Of Patients’ Continuous Ambulatory Respiration Rates

PhysIQ, a company known for applying Artificial Intelligence (AI) in wearable sensor data.

Image: PhysIQ

PhysIQ, a company known for applying Artificial Intelligence (AI) in wearable sensor data, received FDA 510(k) clearance for an algorithm facilitating cloud-based analysis of patients’ continuous ambulatory respiration rates. This regulatory clearance adds to the company’s expanding portfolio of FDA-cleared cloud-based analytics, which also include QRS detection, heart rate, heart rate variability, atrial fibrillation detection, and their personalized physiology change detection analytic.

Read more Omron and physIQ Collaborate to Improve Cardiovascular Patient Care

PhysIQ’s algorithms collect raw telemetry from the device and uploads it to the cloud where FDA-cleared analytics use the raw biosignals to produce vital signs. With this approach physIQ is able to provide vital sign analytics that benefit from the superior computing power of the cloud and fuel the higher-level analytics that further characterize dimensions of human physiology, reports Business Wire.

“In a real-world environment, respiration rate is a tough vital sign to accurately and consistently measure given high levels of motion artifact,” said Matt Pipke, co-founder and CTO of physIQ. “Given these challenges, it is ideal to be able to capitalize on the vast processing power and memory in the cloud to iron out the edge cases and outliers.”

Wearable sensors have enormous potential to transform how we understand and manage human health. However, these on-body sensors are collecting data in a noisy environment and, without sophisticated methods to manage signal noise, the resulting output is compromised.

Read more Netherlands-Based Haga Teaching Hospital Partners with physIQ and VitalConnect for Continuous Monitoring of Cancer Patients

“Accurate and precise vital signs are an essential component of a clinical grade remote intelligence solution but, ultimately, these vital signs are an input into the higher-level AI-based analytics for which physIQ is known,” said Gary Conkright, chairman and CEO of physIQ. “We are encouraged by the successful clearance of respiration as a core dimension of human cardiopulmonary physiology which will accelerate our development of further AI analytics.”

Sam Draper
August 5, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

New TEAL Reusable Respirator Mask Can Sense Proper Fit and Filter Saturation

Researchers at Brigham and Women’s Hospital and MIT have developed a new reusable respirator that...

Lenovo ThinkReality VRX Headset

ThinkReality VRX headgear offers businesses a new enterprise-grade virtual reality solution.

December 2021: Accumold

Accumold has become the first micro molding company to incorporate the Nano Dimension Fabrica 2.0...

MediaTek Launches New Multi-Mode 5G SoC to Power High-End 5G Devices

MediaTek unveiled its groundbreaking 5G chipset for smartphones.
Discover more